Aizen Therapeutics advances Mirror Peptides as new drug class ...Middle East

PR Newswire - News
Caltech AI professor and biotech veterans secure $13M in venture capital to create new category of biologic medicine SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- Aizen Therapeutics, an AI-driven biotechnology company, today emerged from stealth with early-stage programs powered by its novel...

Hence then, the article about aizen therapeutics advances mirror peptides as new drug class was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aizen Therapeutics advances Mirror Peptides as new drug class )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News